ImmunityBio and NantKwest (NK) to Merge,

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. ALHC
3. SPCX
4. PEP
5. T
6. CVS
7. AXP
8. ZETA
9. UNH
10. SBUX

Go back to ImmunityBio and NantKwest (NK) to Merge,

ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company

December 21, 2020 6:05 AM EST

Merged entity brings together 11 Phase II / III clinical trials across oncology and infectious disease that use combined immunotherapy platforms Broad late-stage pipeline for solid tumors including bladder, lung, breast, and pancreatic in addition to infectious disease programs for HIV and COVID-19 Dr. Patrick Soon-Shiong to serve as Executive Chairman, Richard Adcock will be CEO ImmunityBio also today announced that ImmunityBios IL-15 fusion protein, Anktiva, with FDA Breakthrough Therapy status for non-muscle invasive bladder cancer CIS, has achieved... More